Oral Session 2-9A MM: Global clinical trials

[OS2-9A-3] Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in AL Amyloidosis Patients

Camille V. Edwards¹, Divaya Bhutani², Markus Mapara², Jai Radhakrishnan³, Sofia Shames⁴, Mathew S. Maurer⁴, Siyang Leng², Alan Solomon⁵, Suzanne Lentzsch², Andrew Eisenberger² (1.Department of Hematology and Oncology, Boston Medical Center, Boston, United States of America, 2.Division of Hematology and Oncology, Columbia University Medical Center, New York, United States of America, 3.Division of Nephrology, Columbia University Medical Center, New York, United States of America, 4.Division of Cardiology, Columbia University Medical Center, New York, United States of America, 5.Graduate School of Medicine, University of Tennessee, Knoxville, United States of America)